0001562180-19-000343.txt : 20190117
0001562180-19-000343.hdr.sgml : 20190117
20190117175238
ACCESSION NUMBER: 0001562180-19-000343
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20190117
FILED AS OF DATE: 20190117
DATE AS OF CHANGE: 20190117
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Velleca Mark A.
CENTRAL INDEX KEY: 0001706847
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-38096
FILM NUMBER: 19531703
MAIL ADDRESS:
STREET 1: 79 TW ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: G1 Therapeutics, Inc.
CENTRAL INDEX KEY: 0001560241
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 263648180
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 79 T.W. ALEXANDER DRIVE
STREET 2: 4501 RESEARCH COMMONS, SUITE 100
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
BUSINESS PHONE: 919-213-9835
MAIL ADDRESS:
STREET 1: P. O. BOX # 110341
CITY: RESEARCH TRIANGLE PARK
STATE: NC
ZIP: 27709
FORMER COMPANY:
FORMER CONFORMED NAME: G-Zero Therapeutics, Inc.
DATE OF NAME CHANGE: 20121012
4
1
primarydocument.xml
PRIMARY DOCUMENT
X0306
4
2019-01-17
false
0001560241
G1 Therapeutics, Inc.
GTHX
0001706847
Velleca Mark A.
C/O G1 THERAPEUTICS, 79 TW ALEXANDER DR.
4501 RESEARCH COMMONS, SUITE 100
RESEARCH TRIANGLE PARK
NC
27709
true
true
false
false
President and CEO
Common Stock
2019-01-17
4
M
false
9000.00
0.39
A
28000.00
D
Stock Options (Right to Buy)
0.39
2019-01-17
4
M
false
9000.00
0.00
D
2024-05-09
Common Stock
9000.00
380286.00
D
All shares underlying this option have vested.
/s/ James Stillman Hanson, attorney-in-fact
2019-01-17